Kyle R. Cron
University of Chicago(US)Io Therapeutics (United States)(US)
Publications by Year
Research Areas
Cytokine Signaling Pathways and Interactions, Retinoids in leukemia and cellular processes, Nuclear Receptors and Signaling, Cancer Immunotherapy and Biomarkers, Ubiquitin and proteasome pathways
Most-Cited Works
- → CD47 blockade triggers T cell–mediated destruction of immunogenic tumors(2015)745 cited
- → IFN-γ Mediates the Antitumor Effects of Radiation Therapy in a Murine Colon Tumor(2013)121 cited
- → Proteasome Inhibitors Block DNA Repair and Radiosensitize Non-Small Cell Lung Cancer(2013)54 cited
- → USP9X inhibition promotes radiation-induced apoptosis in non-small cell lung cancer cells expressing mid-to-high MCL1(2015)33 cited
- → cDC1 dysregulation in cancer: An opportunity for intervention(2020)14 cited
- → Severe COVID-19 infection is associated with aberrant cytokine production by infected lung epithelial cells rather than by systemic immune dysfunction(2021)10 cited
- → Abstract S04-02: Treatment with tocilizumab does not inhibit induction of anti-COVID-19 antibodies in patients with severe SARS-CoV-2 infection(2020)2 cited
- → Abstract 576: ACTM-838, a novel immunotherapy that enriches in solid tumors after IV dosing and comprehensively reverses the immunosuppressive TME to promote durable anti-tumor immunity(2023)1 cited
- → 642 Decreased host PKC-delta is associated with the T cell-inflamed tumor microenvironment and improves anti-tumor immunity(2021)1 cited